OM

SEC source: 0001484612-23-000058 · edgardoc.xml · nonDerivative · entry 1

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 429,489

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 23, 2023.

SEC source: 0001484612-23-000057 · edgardoc.xml · nonDerivative · entry 1

Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 90,736

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023.

SEC source: 0001484612-23-000056 · edgardoc.xml · nonDerivative · entry 2

Nash Marc · CIK 0001983815 · VP Manufacturing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,533

F2 · shares: Represents a portion of stock units granted to the reporting person on July 24, 2023 that will vest on December 31, 2025, subject only to the reporting person's continuous service through the vesting date. Each stock unit represents a contingent right to receive one share of common stock.

SEC source: 0001484612-23-000056 · edgardoc.xml · nonDerivative · entry 1

Nash Marc · CIK 0001983815 · VP Manufacturing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,195

F1 · shares: Represents restricted stock units ("RSU") granted to the reporting person on July 24, 2023. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on July 24, 2024, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date.

SEC source: 0001484612-23-000054 · edgardoc.xml · derivative · entry 3

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,560

Underlying: Common Stock · 1,415 shares

Expires 2030-05-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023.

F2 · derivative.exercise_date: This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.

SEC source: 0001484612-23-000054 · edgardoc.xml · nonDerivative · entry 2

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 58,945

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023.

SEC source: 0001484612-23-000054 · edgardoc.xml · nonDerivative · entry 1

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 60,360

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023.

SEC source: 0001484612-23-000052 · edgardoc.xml · nonDerivative · entry 1

Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 91,726

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023.

SEC source: 0001484612-23-000053 · edgardoc.xml · derivative · entry 4

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 45,418

Underlying: Common Stock · 20,000 shares

Expires 2028-11-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 23, 2023.

F3 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.

SEC source: 0001484612-23-000053 · edgardoc.xml · nonDerivative · entry 2

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 409,489

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 23, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $20.00 - $20.99 - 13,150 shares; and $21.00 - $21.99 - 6,850 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote.

SEC source: 0001484612-23-000053 · edgardoc.xml · nonDerivative · entry 1

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 429,489

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 23, 2023.

SEC source: 0001484612-23-000051 · edgardoc.xml · derivative · entry 3

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,975

Underlying: Common Stock · 1,414 shares

Expires 2030-05-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.

SEC source: 0001484612-23-000051 · edgardoc.xml · nonDerivative · entry 2

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 58,945

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023.

SEC source: 0001484612-23-000051 · edgardoc.xml · nonDerivative · entry 1

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 60,359

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001484612-23-000049 · edgardoc.xml · nonDerivative · entry 1

Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 92,716

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023.

SEC source: 0001484612-23-000050 · edgardoc.xml · derivative · entry 4

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 65,418

Underlying: Common Stock · 20,000 shares

Expires 2028-11-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 23, 2023.

F3 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.

SEC source: 0001484612-23-000050 · edgardoc.xml · nonDerivative · entry 2

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 409,489

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 23, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $20.00 - $20.99 - 8,988 shares; $21.00 - $21.99 - 11,012 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote.

SEC source: 0001484612-23-000050 · edgardoc.xml · nonDerivative · entry 1

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 429,489

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 23, 2023.

SEC source: 0001484612-23-000048 · edgardoc.xml · nonDerivative · entry 1

Szyman Catherine M. · CIK 0001438538 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,596

F1 · kind: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders

SEC source: 0001484612-23-000047 · edgardoc.xml · nonDerivative · entry 1

Saia Andrea Lynn · CIK 0001552993 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,892

F1 · kind: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders

SEC source: 0001484612-23-000046 · edgardoc.xml · nonDerivative · entry 1

HACKETT PATRICK T · CIK 0001238606 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,849

F1 · kind: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders

SEC source: 0001484612-23-000045 · edgardoc.xml · nonDerivative · entry 1

JONES DALE E · CIK 0001261562 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,918

F1 · kind: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders

SEC source: 0001484612-23-000044 · edgardoc.xml · nonDerivative · entry 1

Hinrichs James F. · CIK 0001506974 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,349

F1 · kind: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders

SEC source: 0001484612-23-000043 · edgardoc.xml · nonDerivative · entry 1

GROSSMAN D KEITH · CIK 0001218702 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,849

F1 · kind: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders

SEC source: 0001484612-23-000042 · edgardoc.xml · nonDerivative · entry 1

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,232

F1 · kind: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders

SEC source: 0001484612-23-000041 · edgardoc.xml · derivative · entry 5

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,389

Underlying: Common Stock · 1,415 shares

Expires 2030-05-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023.

F3 · derivative.exercise_date: This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.

SEC source: 0001484612-23-000041 · edgardoc.xml · nonDerivative · entry 4

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 58,945

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023.

SEC source: 0001484612-23-000041 · edgardoc.xml · nonDerivative · entry 3

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 60,262

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023.

SEC source: 0001484612-23-000041 · edgardoc.xml · nonDerivative · entry 2

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 61,677

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023.

SEC source: 0001484612-23-000040 · edgardoc.xml · nonDerivative · entry 1

Racine Jean-Olivier · CIK 0001868039 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,227

F1 · price: The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on May 16, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.

F2 · balance_after: Includes 1,422 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2022 to February 28, 2023. This transaction is exempt from Rule 16b-3(c).

SEC source: 0001484612-23-000039 · edgardoc.xml · nonDerivative · entry 1

Porter Stacey L. · CIK 0001889204 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,704

F1 · price: The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on May 16, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.

F2 · balance_after: Includes 1,422 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2022 to February 28, 2023. This transaction is exempt from Rule 16b-3(c).

SEC source: 0001484612-23-000038 · edgardoc.xml · nonDerivative · entry 1

Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,706

F1 · price: The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on May 16, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.

SEC source: 0001484612-23-000037 · edgardoc.xml · nonDerivative · entry 1

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 409,489

F1 · price: The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on May 16, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.

SEC source: 0001484612-23-000036 · edgardoc.xml · nonDerivative · entry 1

Williamson Steven S. · CIK 0001478582 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 117,212

F1 · price: The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on May 16, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.

SEC source: 0001484612-23-000041 · edgardoc.xml · nonDerivative · entry 1

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 60,262

F1 · price: The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on May 16, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.

SEC source: 0001484612-23-000035 · edgardoc.xml · nonDerivative · entry 1

Williamson Steven S. · CIK 0001478582 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 117,893

F1 · balance_after: Includes 1,422 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2022 to February 28, 2023. This transaction is exempt from Section 16, pursuant to Rule 16b-3(c).

SEC source: 0001484612-23-000033 · edgardoc.xml · derivative · entry 3

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 19,804

Underlying: Common Stock · 1,414 shares

Expires 2030-05-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023.

F2 · derivative.exercise_date: This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.

SEC source: 0001484612-23-000033 · edgardoc.xml · nonDerivative · entry 2

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 61,597

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023.

SEC source: 0001484612-23-000033 · edgardoc.xml · nonDerivative · entry 1

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 63,011

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023.

SEC source: 0001484612-23-000034 · edgardoc.xml · nonDerivative · entry 1

Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 95,238

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023.

F2 · balance_after: Includes 878 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2022 to February 28, 2023. This transaction is exempt from Section 16, pursuant to Rule 16b-3(c).

SEC source: 0001484612-23-000032 · edgardoc.xml · derivative · entry 10

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 85,418

Underlying: Common Stock · 9,492 shares

Expires 2028-11-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 23, 2023.

F4 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.

SEC source: 0001484612-23-000032 · edgardoc.xml · derivative · entry 9

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 94,910

Underlying: Common Stock · 20,000 shares

Expires 2028-11-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 23, 2023.

F4 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.

SEC source: 0001484612-23-000032 · edgardoc.xml · derivative · entry 8

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,508 shares

Expires 2027-09-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 23, 2023.

F3 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.

SEC source: 0001484612-23-000032 · edgardoc.xml · nonDerivative · entry 6

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 412,451

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 23, 2023.

SEC source: 0001484612-23-000032 · edgardoc.xml · nonDerivative · entry 5

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 422,959

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 23, 2023.

SEC source: 0001484612-23-000032 · edgardoc.xml · nonDerivative · entry 4

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 412,451

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 23, 2023.

SEC source: 0001484612-23-000032 · edgardoc.xml · nonDerivative · entry 3

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 421,943

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 23, 2023.

SEC source: 0001484612-23-000032 · edgardoc.xml · nonDerivative · entry 2

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 412,451

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 23, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. The 20,000 shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $20.00-$20.03. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001484612-23-000032 · edgardoc.xml · nonDerivative · entry 1

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 432,451

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 23, 2023.

SEC source: 0001140361-23-012810 · form4.xml · derivative · entry 4

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,218

Underlying: Common Stock · 1,415 shares

Expires 2030-05-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.